Historical record - last NADAC effective date: 7/17/2024
Product Information
CAPECITABINE 500 MG TABLET is a generic product labeled by Armas Pharmaceuticals Inc., priced at $0.4615 per EA under NDC 72485020512. Its NADAC has been published 251 times since Oct 30, 2019.
FDA first approved this application on Dec 12, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Armas Pharmaceuticals Inc.NDC
72485020512
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
CAPECITABINEApproval Type
Generic (ANDA)
FDA Application
ANDA207456FDA Approved
12/12/2016
TE Code
AB
On Market Since
3/1/2019
Pharmacological Classes
Price Statistics
The NADAC for CAPECITABINE 500 MG TABLET has been published 251 times since Oct 30, 2019, and over the history we have for it it has declined 87.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4615 per EA |
|---|---|
| All-time high | $3.6868 (May 13, 2020) |
| All-time low | $0.4615 (Jul 17, 2024) |
| Median price | $0.5863 |
| Average price | $1.0911 |
| Largest weekly change | -67.4% (Dec 23, 2020) |
| Weeks tracked | 251 |
| Tracking since | Oct 30, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-13.7%
5Y
-21.3%
All
-87.5%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Armas Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Capecitabine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nucleoside Metabolic Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CAPECITABINE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 500 MG TABLET, manufactured by Armas Pharmaceuticals Inc., is $0.4615 per EA (NDC 72485020512), effective Aug 14, 2024.
How has the price of CAPECITABINE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPECITABINE 500 MG TABLET has declined 87.5%. It has been tracked across 251 weekly CMS publications since Oct 30, 2019.
What are the highest and lowest recorded NADAC prices for CAPECITABINE 500 MG TABLET?
Since Oct 30, 2019, the NADAC for CAPECITABINE 500 MG TABLET has ranged from a low of $0.4615 (Jul 17, 2024) to a high of $3.6868 (May 13, 2020), with a median of $0.5863 per EA.
Are there cheaper alternatives to CAPECITABINE 500 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CAPECITABINE 500 MG TABLET, is $0.4556 per EA — about 1% below CAPECITABINE 500 MG TABLET.
Who manufactures CAPECITABINE 500 MG TABLET?
CAPECITABINE 500 MG TABLET (NDC 72485020512) is labeled by Armas Pharmaceuticals Inc., and CMS classifies it as a generic product.